CYTOVAC A/S: Financial statements 2012
CVR: 31262666
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -5,240,827 and a net result of DKK -10,927,052. Equity in the 2012 report amounted to DKK 12,830,279. The solvency ratio was 83.9%.
- Gross Profit
- DKK -5,240,827
- Profit/Loss
- DKK -10,927,052
- Equity
- DKK 12,830,279
- Total Assets
- DKK 15,294,111
Official annual report
Keep an eye on CYTOVAC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 22, 2012, Hans Christian Petersen has joined the board of directors of CYTOVAC A/S.
As of May 22, 2012, Jarne Elleholm has joined the board of directors of CYTOVAC A/S.
As of February 26, 2012, Gert Toftkjær has left the board of directors of CYTOVAC A/S.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.